COCH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Envoy Medical Inc (COCH) is not a strong buy for a beginner, long-term investor at this time. The stock lacks clear positive signals from technical indicators, proprietary trading signals, and financial performance. While insider buying and regained Nasdaq compliance are positive, the company's weak financials and lack of significant upward momentum suggest holding off on investment until further improvements are observed.
The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 54.338, and moving averages are converging, showing no clear trend. Key resistance levels are at 0.764 and 0.837, while support levels are at 0.528 and 0.455. Overall, the technical indicators do not strongly favor a buy.
Insiders are buying significantly, with a 55882.60% increase in the last month. The company has regained Nasdaq compliance, which may boost investor confidence. A public offering of $78 million could strengthen the capital base for future expansion.
The company has a history of failing to meet Nasdaq's market value requirements. Financial performance is weak, with a 25% YoY revenue drop and negative EPS. The stock price has been declining, with a -2.38% regular market change and a -1.02% pre-market change.
In Q3 2025, revenue dropped by 25% YoY to $42,000. Net income improved slightly but remains negative at -$7,747,000. EPS decreased by 5.41% YoY to -0.35. Gross margin improved but is still negative at -383.33%. Overall, the financials indicate poor performance.
No data available for analyst ratings or price target changes.
